Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Biogen and Tsinghua University Launch Three-Year Neuroscience Collaboration
January 26, 2025
Policy / Regulatory
China’s NHC and NATCM Launch Integrated Pain Management Pilot Plan
January 26, 2025
Company
Deals
Zhongchao Partners with Natco Pharma to Distribute Drugs in China
January 26, 2025
Company
Deals
By-Health to Establish Nutrition Research Center with Shanghai Institute
January 26, 2025
Company
Deals
CANbridge Secures Global Rights to Second-Generation Gene Therapy for SMA
January 26, 2025
Company
Drug
Transcenta’s TST003 Receives Clinical Trial Approval in China and US
January 26, 2025
Company
Drug
Henlius’ Hanbeitai Gains NMPA Approval for Expanded Indications
January 26, 2025
Company
Deals
Sihuan’s Hui Sheng Bio Completes Series A+ Financing for Diabetes Pipeline
January 26, 2025
Company
Drug
HutchMed Completes Enrollment for Phase III ESLIM-01 Study of Sovleplenib in ITP
January 26, 2025
Company
Drug
RemeGen’s RC48 Gains NMPA Approval for Phase II Study in Bladder Cancer
January 26, 2025
Company
Deals
Apeloa and Simcere Partner for CDMO Services and R&D Collaboration
January 26, 2025
Company
Deals
Sino Biopharmaceutical’s CTTQ Partners with ProteLight for Antibacterial Peptide PL-5
January 26, 2025
1
2
…
1,057
1,058
1,059
1,060
1,061
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?